Area of research
Applied Microbiology and Biotechnology · Molecular Medicine
Research interest
Research interests include Antibiotic Use and Resistance, Antibiotic Resistance in Bacteria, Bacterial Identification and Susceptibility Testing, and Antimicrobial Resistance in Staphylococcus.
Development and implementation of an electronic admission-screening tool for Candidozyma auris (formerly Candida auris) at a large healthcare system in Miami, FL, USA
Pathogen genomics in healthcare: overcoming barriers to proactive surveillance
Factors Associated With Poor Clinical and Microbiologic Outcomes in <i>Candida auris</i> Bloodstream Infection: A Multicenter Retrospective Cohort Study
Navigating the Challenges of Candida auris Colonization in Rehabilitation Settings
Development and validation of an antimicrobial stewardship clinical decision-support tool to improve the management of urinary tract infections versus asymptomatic bacteriuria in hospitalized patients
Impact of In-house <i>Candida auris</i> Polymerase Chain Reaction Screening on Admission on the Incidence Rates of Surveillance and Blood Cultures With <i>C. auris</i> and Associated Cost Savings
Clinical prediction models for mortality in patients with covid-19: external validation and individual participant data meta-analysis
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
Use of maintenance therapy and incidence of recurrent Cytomegalovirus DNAemia among allogeneic hematopoietic cell transplant recipients
Mycobacterium abscessus Complex Infections: A Retrospective Cohort Study
Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa
Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients
<i>In Vitro</i> Discordance with <i>In Vivo</i> Activity: Humanized Exposures of Ceftazidime-Avibactam, Aztreonam, and Tigecycline Alone and in Combination against New Delhi Metallo-β-Lactamase-Producing Klebsiella pneumoniae in a Murine Lung Infection Model
Phaeohyphomycosis due to <i>Exophiala</i> infections in solid organ transplant recipients: Case report and literature review
Application of “Precision Medicine” Through the Molecular Characterization of Extensively Drug-Resistant Klebsiella pneumoniae in a Multivisceral Transplant Patient
“Double carbapenem” and oral fosfomycin for the treatment of complicated urinary tract infections caused by <i>bla</i><sub>NDM</sub>‐harboring Enterobacteriaceae in kidney transplantation
Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates
Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus–Infected Kidney Allograft Recipients
Solid organ transplant antibiograms: an opportunity for antimicrobial stewardship
Evaluating the Impact of Antibiotic Exposures as Time-Dependent Variables on the Acquisition of Carbapenem-Resistant Acinetobacter baumannii*
Impact of antiretroviral therapy on clinical outcomes in HIV+ kidney transplant recipients: Review of 58 cases
Influence of immune activation on the risk of allograft rejection in human immunodeficiency virus-infected kidney transplant recipients
Surveillance Cultures Growing Carbapenem-Resistant Acinetobacter baumannii Predict the Development of Clinical Infections: A Retrospective Cohort Study
Environmental Exposure to Carbapenem-Resistant <i>Acinetobacter baumannii</i> as a Risk Factor for Patient Acquisition of <i>A. baumannii</i>
Differential environmental contamination with Acinetobacter baumannii based on the anatomic source of colonization